Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs.

Authors:
Su X; Zhou C; Chen S; Ma Q; Xiao H and 2 more

Journal:
Oncol Lett

Publication Year: 2024

DOI:
10.3892/ol.2024.14264

PMCID:
PMC10867731

PMID:
38362233

Journal Information

Full Title: Oncol Lett

Abbreviation: Oncol Lett

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"The present study was funded by the Chongqing Science and Health Joint Medical Research Project (grant no. 2021MSXM327) and the special subject of improving scientific and technological innovation ability of the Military Medical University (grant no. 2020XQN21)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025